Skip to main content
Signal8

Bionovate Technologies Corp (BIIO)

Bionovate Technologies Corp. is a medical device enterprise dedicated to pioneering automated solutions for the treatment of age spots. Its core objective is to engineer a sophisticated, computer-driven system designed to precisely target and treat these blemishes on any area of the body. The firm plans to distribute these advanced systems globally, marketing them to healthcare providers and wellness centers. Founded in Cham, Switzerland, in 2010, the organization previously traded under the name MJP International Ltd. before adopting Bionovate Technologies Corp. in December 2017. Since October 7, 2020, the company has operated as an affiliated entity of Human Data AG.

Sector: Medical - Devices

Industry: Medical - Devices

Bionovate Technologies Corp logo

Bionovate Technologies Corp

OTC:BIIOHealthcare
CLOSED
Mkt Cap-
EV-
Float3.95M
O/S7.75M
VOL2K sh
RVOL0.64×
Inst Own-
SI<0.1%
Net Cash/Sh+$0.00
Dilution
Financials Summary
Revenue$0
Net Income-$107K
Total Assets$0
Free Cash Flow-$236
Debt & Equity
Total Debt$0
Total Equity-$151K
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
  1. 1:100Reverse split
    Jan 9, 2020100 shares → 1
Balance Sheet Details
Assets$936
Liabilities$152K
Accounts Receivable$0
Accounts Payable$21K
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-30
Revenue$0$0$0$0$5K$6K$4K$8K$29K$35K$23K
YoY Growth-----12.0%37.9%-46.2%-71.4%-17.1%51.7%-
Cost of Revenue$0$0$0$0$4K$5K$4K$10K$26K$17K$39K
Gross Profit$0$0$0$0$906$1K$682-$2K$3K$18K-$16K
Gross Margin----16.8%16.5%15.4%-22.4%9.7%52.3%-71.5%
Research and Development$0$0$0$0$0$0$0$0$0$0$0
Selling, General, and Administrative$45K$33K$57K$119K$89K$39K$49K$89K$90K$14K$1K
Other$0$0$0$0$0$0$0$0$0$0$0
Total Operating Expenses$45K$33K$57K$119K$89K$39K$49K$89K$90K$14K$1K
Operating Income (EBIT)-$45K-$33K-$57K-$119K-$88K-$38K-$48K-$91K-$88K$4K-$18K
Operating Margin-----1628.9%-627.0%-1086.9%-1105.6%-303.5%12.1%-77.1%
Interest Expense$61K$89K$152K$67K$61K$0$0$0$0$0$0
Interest Income$0$0$0$0$0$0$0$0$0$0$0
Other Income (Expense)-$61K-$89K-$152K-$1.62M-$253K$0$0$0$0$0$0
Income Before Tax (EBT)-$107K-$122K-$209K-$1.74M-$341K-$38K-$48K-$91K-$88K$4K-$18K
Income Tax Expense$0$0$0$0$0$0$0$0$0$1K$0
Net Income-$107K-$122K-$209K-$1.74M-$323K-$38K-$48K-$91K-$88K$3K-$18K
Net Income Margin-----6002.8%-627.0%-1086.9%-1105.6%-303.5%8.2%-77.1%
Supplementary Data
EPS-0.00-0.00-1.34-27.63-1.09-0.12-0.10-0.30-0.300.00-5.50
Diluted EPS-0.00-0.00-1.34-27.46-1.09-0.12-0.10-0.30-0.300.00-5.50
Weighted Average OS7.75M25.00M155,00063,0000000003,222
EBITDA-$240-$6K$44K-$68K-$227K-$38K-$48K-$91K-$88K$4K-$18K
EBITDA Margin-----4220.6%-627.0%-1086.9%-1105.6%-303.5%12.1%-77.1%
Balance Sheet
PeriodFY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-30
Assets
Current Assets
Cash and Cash Equivalents$0$0$0$0$0$936$617$967$58K$614$1K
Short-Term Investments$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$0$0$0$0$0$936$617$967$58K$614$1K
Accounts Receivable$0$0$0$0$0$0$0$0$0$338$9K
Inventory$0$0$0$0$0$0$0$0$8K$9K$0
Other Current Assets$0$0$0$0$0$0$0$0$0$0$0
Total Current Assets$0$0$0$0$0$936$617$967$66K$10K$10K
Long-Term Assets
Property, Plant & Equipment Net$0$0$0$0$0$0$0$0$0$0$0
Goodwill$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0$0$0$0$0$0$0$0$0
Total Long-Term Assets$0$0$0$0$0$0$0$0$0$0$0
Other Assets$0$0$0$0$0$0$0$0$0$0$0
Total Assets$0$0$0$0$0$936$617$967$66K$10K$10K
Liabilities
Current Liabilities
Accounts Payable$32K$26K$22K$41K$39K$21K$22K$10K$24K$15K$14K
Short-Term Debt$237K$185K$184K$269K$190K$0$0$0$0$0$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0
Other Current Liabilities$41K$0$41K$0$0$130$95$66K$34K$9K$14K
Total Current Liabilities$503K$397K$332K$310K$229K$152$117$84K$57K$24K$29K
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0$0$0$0$0$0$0
Total Long-Term Liabilities$0$0$0$0$0$0$0$0$0$0$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$503K$397K$332K$310K$229K$152K$117K$84K$57K$24K$29K
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0
Common Stock$775$6K$15$2K$30$32$2K$2K$2K$1K$104
Retained Earnings-$2.8M-$2.7M-$2.58M-$2.37M-$627K-$280K-$242K-$194K-$102K-$15K-$18K
Comprehensive Income & Other$0$0-$0$0$14K$16K$12K-$3K-$3K$0-$684
Other Stockholders' Equity$2.3M$2.3M$2.24M$2.06M$397K$129K$124K$109K$109K$0-$685
Total Equity-$503K-$397K-$332K-$310K-$229K-$151K-$116K-$83K$9K-$14K-$18K
Minority Interest$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$0$0$0$0$0$936$617$967$66K$11K$10K
Supplementary Data
Total Debt$237K$185K$184K$269K$190K$0$0$0$0$0$0
Net Debt$237K$185K$184K$269K$190K-$936-$617-$967-$58K-$614-$1K
Cash Flow Statement
PeriodFY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-30
Operating Activities
Net Income-$107K-$122K-$209K-$1.74M-$324K-$38K-$48K-$91K-$88K$3K
Depreciation & Amortization$45K$27K$101K$51K$53K$0$0$0$0$0
Deferred Income Tax$0$0$0$0$0$0$0$0$0$0
Stock-Based Compensation$0$0$0$0$0$0$0$0$0$0
Changes in Working Capital:
  Accounts Receivable$0$0$0$0$0$0$0$0$338$9K
  Inventory$0$0$0$0$0$0$0$8K$475-$9K
  Accounts Payable$54K$68K$67K$42K$10K$425$0$0$7K$0
  Other Working Capital$0$0$0$65K$73K$50K$48K$32K$16K$0
Total Working Capital Change$54K$68K$67K$107K$83K$51K$48K$41K$23K-$299
Other Non-Cash Items$7K$27K$41K$79K$198K-$12K-$15K-$6K$0$901
Net Cash from Operating-$236$102-$292-$1.5M$11K$429-$15K-$56K-$64K$3K
Investing Activities
Capital Expenditures$0$0$0$0$0$0$0$0$0$0
Acquisitions$0$0$0$0$2K$0$0$0$0$0
Purchases of Investments$0$0$0$0$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$0$0$0$0$0
Other Investing Activities$0$0$0$0$5K$0$0$0$0$0
Net Cash from Investing$0$0$0$0$7K$0$0$0$0$0
Financing Activities
Debt Repaid----$0-----
Common Stock Issuance$0$30K$0$11K$0$0$0$0$121K$0
Common Stock Repurchases$0$0$0$0-$23K$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$30K$0$11K$0$0$0$0$229-$5K
Net Cash from Financing$0$30K$0$11K-$18K$0$0$0$121K-$5K
Forex Effect$0$0$0$0-$1K-$110$15K-$357$318$936
Net Change in Cash-$236$31K-$292-$1.49M-$936$319-$350-$57K$57K-$863
Supplementary Data
Operating Cash Flow-$236$102-$292-$1.5M$11K$429-$15K-$56K-$64K$3K
Capital Expenditure$0$0$0$0$0$0$0$0$0$0
Free Cash Flow-$236$102-$292-$1.5M$11K$429-$15K-$56K-$64K$3K
Cash at Beginning$102-$30K$0$0$936$617$967$58K$614$1K
Cash at End-$236$102-$292-$1.49M$0$936$617$967$58K$614